Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSPEMIFENE for Off label use: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 346 adverse event reports in the FDA FAERS database where OSPEMIFENE was used for Off label use.

Most Reported Side Effects for OSPEMIFENE

Side Effect Reports % Deaths Hosp.
Off label use 387 18.9% 0 11
Hot flush 319 15.6% 0 0
Headache 171 8.4% 0 4
Muscle spasms 164 8.0% 0 1
No adverse event 160 7.8% 0 0
Vaginal haemorrhage 127 6.2% 0 2
Vaginal discharge 112 5.5% 0 0
Labelled drug-drug interaction medication error 104 5.1% 0 2
Hyperhidrosis 95 4.6% 0 0
Nausea 79 3.9% 0 3
Drug ineffective 69 3.4% 0 2
Therapeutic response unexpected 68 3.3% 0 0
Pain in extremity 63 3.1% 0 2
Weight increased 63 3.1% 0 0
Rash 62 3.0% 0 0

Other Indications for OSPEMIFENE

Product used for unknown indication (946) Dyspareunia (601) Vulvovaginal dryness (282) Atrophic vulvovaginitis (169) Atrophy (20) Urinary tract infection (18) Vulvovaginal pain (15) Vulvovaginal burning sensation (14) Vulvovaginal discomfort (13) Menopausal symptoms (10)

Other Drugs Used for Off label use

LENALIDOMIDE (5,767) ECULIZUMAB (3,550) CERTOLIZUMAB PEGOL (2,256) ABOBOTULINUMTOXINA (2,170) LEVETIRACETAM (2,161) APREMILAST (1,995) PROPRANOLOL (1,576) CETIRIZINE (1,416) HUMAN IMMUNOGLOBULIN G (1,129) THALIDOMIDE (1,033)

Related Pages

OSPEMIFENE Full Profile All Off label use Drugs OSPEMIFENE Demographics OSPEMIFENE Timeline